These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7521438)

  • 41. Cardiotoxicity of interferon. A review of 44 cases.
    Sonnenblick M; Rosin A
    Chest; 1991 Mar; 99(3):557-61. PubMed ID: 1704826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patient tolerance to interferon: clinical and laboratory assessments.
    Fischl MA
    Med Clin North Am; 1986 May; Suppl():41-5. PubMed ID: 2426535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy.
    Okuma Y; Kimura K; Saeki S; Hishima T; Hayashi S
    Clin J Gastroenterol; 2009 Oct; 2(5):346-350. PubMed ID: 26192611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of hepatitis C virus infection and associated vascular complications: a literature review.
    Karbasi-Afshar R
    Iran J Med Sci; 2014 May; 39(3):238-46. PubMed ID: 24850980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms.
    Jones Buie JN; Oates JC
    Am J Med Sci; 2014 Aug; 348(2):168-75. PubMed ID: 24796291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is combination therapy for chronic hepatitis C toxic for cardiac function?
    Almawardy R; Elhammady W; Mousa N; Abotaleb S
    Hepat Mon; 2012 Aug; 12(8):e6254. PubMed ID: 23105944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
    Otsubo T; Miyaoka H; Kamijima K; Onuki M; Ishii M; Mitamura K
    Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interstitial pneumonia induced by interferon therapy in type C hepatitis].
    Karino Y; Hige S; Matsushima T; Toyota J
    Nihon Rinsho; 1994 Jul; 52(7):1905-9. PubMed ID: 7521437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Interferon-associated retinopathy].
    Okuno H; Hirota T; Shiozaki Y; Inoue K; Hagihara M; Sugasawa K; Okami T
    Nihon Rinsho; 1994 Jul; 52(7):1919-23. PubMed ID: 7521439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cardiovascular complications of interferon therapy in chronic hepatitis C].
    Kouno H; Aimitsu S; Ikemoto Y; Nakanishi T; Kajiyama G
    Nihon Rinsho; 1994 Jul; 52(7):1914-8. PubMed ID: 7521438
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.